BioResearch Product Faire™
Most people don’t think of the flu as being life threatening. However, 36,000 American’s die because of the flu virus each year. Now, with the help of millions in NIH research funding, scientists at Rockefeller University have devised a strategy for improving existing flu vaccines. The new vaccines will better protect people against these ever-mutating viruses. And this new strategy might eliminate the need for annual flu shots, while at the same time saving thousands of lives.Read More
Tags: Rockefeller University, influenza research, RockU, Research Funding, Life Sciences, life science researchers, laboratory equipment suppliers, Lab Product Sales, Biomedical Research Funding, BioResearch Product Faire, Biotechnology trade show, biotech services, nih research funding
Dr. Robert Darnell, Professor of Cancer Biology and Head of the Laboratory of Molecular Neuro-Oncology at Rockefeller University, received a $1.1 million grant from the NIH’s National Institute of Neurological Disorders and Stroke.
This research funding will support his lab’s new approach to studying diseases of the brain through modern biotech services and more efficient informatics. He and his lab will work on harnessing the power of molecular biology to define therapeutic targets for several different types of brain diseases. Researchers will do this by combining the latest technological advances modern science has brought to neuroscience with new computational approaches.Read More
Rockefeller University received a $25 million gift from the Robertson Foundation that will be used to create the Robertson Therapeutic Development Fund. This fund will be used to help turn basic research discoveries into new medical therapies by providing support for dozens of Rockefeller projects over the next five years. Research grants ranging from $10,000 to $1 million will be awarded from the fund in order to provide Rockefeller scientists with the resources they need to take exceptionally promising research initiatives through the steps that lead to breakthrough medications, new diagnostic tests or other clinical innovations.Read More
Rockefeller University is currently experiencing one of the largest phases of research expansion in its modern history. To accommodate for its expanding research capabilities as a competitive institution, Rockefeller University officials have already begun implementing changes to grow the campus and construct new research buildings and institutes all together.Read More
Updated 12/8/2016, originally posted by Laura Braden 2/2/16
Understanding what stem cells do and why they are important has been a popular research topic for many years. Scientists have learned quite a bit about their functions, such as repairing damaged tissues and renewing some normal ones. However, there is no knowledge of where these stem cells originate and how they develop in the embryo.Read More
Neuroscientists at Rockefeller University in New York will be making breakthroughs in a brand new institute, according to a recent announcement from the university and the Kavli Foundation. The new Kavli Neural Systems Institute (Kavli NSI) will be located at Rockefeller University, thanks in part to a $20 million endowment supported equally by Kavli and Rockefeller.Read More
Tags: Rockefeller University, East Coast Bioscience Shows, New York, Neuroscience, RockU, Research Funding, NY, New York City, Northeast Region, NIH funding, 2016, BioResearch Product Faire™, Kavli Institute
Millions of dollars are awarded annually to researchers and research centers focusing on digestive disorders, including the University of California system schools, the major medical universities and hospitals across the country and top research Institutions such as Scripps, Salk andOn the east coast, Rockefeller University in New York, was recently awarded a Read More
The flu is something that everyone experiences at some time. Even after receiving an annual flu shot, many people still fall ill due to a different strain of the flu that the shot does not protect against. Generally, the flu shot protects against three common strains of influenza, leaving people still vulnerable to getting the flu. Researchers at Rockefeller University have developed a new method of creating the flu vaccine that could potentially work against many more strains of influenza. (Image courtesy of Wikimedia Commons).
In collaboration with researchers at The Scripps Research Institute, Weill Cornell Medical College, and other institutions, scientists at Rockefeller University are working to harness the natural potential of the human immune system to develop a series of sequential vaccinations against the HIV virus.Read More
Tags: Rockefeller University, Bioresearch, HIV, Bioscience, infectious diseases, New York, 2015, disease research, RockU, BioResearch Product Faire Event, NY, NIH, Northeast Region, AIDS vaccine research, life science tradeshows